CD34 and renal cell carcinoma: To explore the clinical relevance of VEGFR2/NRP1 trans complexes in RCC and the associated vessel parameters, staining for NRP1, VEGFR2, and CD34 was performed on an independent validation cohort of 314 RCC patients (see material and methods for details).